Food and Drug Administration (FDA) in 1990 and 1997, respectively, for the treatment of idiopathic growth hormone deficiency (GHD) in children with growth failure, or for evaluating the ability of the growth hormone producing cells, called somatotrophs, of the pituitary gland to secrete growth hormone
Nearly every SLE patient takes it, and guidelines recommend it be continued indefinitely
Primary care is the right next step when fatigue, numbness, dizziness, or medication-related questions need broader evaluation
Life Sci (2006) 7821:241925
Subjectively, adequate B12 manifests as maintained energy levels, absence of neurological symptoms like numbness or tingling, and normal cognitive function
More research is needed to fully understand the connection between GLP-1 medications and stomach side effects